Cheah CY, Lingaratnam S, Seymour JF. Rituximab for the treatment of follicular lymphoma. Future Oncol 2013; 9: 1283-98.Chan YCheah, SenthilLingaratnam, John FSeymour. (2013) Rituximab for the treatment of follicular lymphoma. Future Oncology 9 , 1283-1298 /...
14 For relapsed disease, these factors, in addition to the choice of prior therapy and the length of remission duration from first treatment, will influence treatment decisions. Despite treatment, the vast majority of patients relapse and CLL remains an incurable disease.15 Randomized con...
Kidney Problems:especially if you are receiving Rituxan for non–Hodgkin’s lymphoma (NHL). Rituxan can cause severe kidney problems that lead to death. Your healthcare provider should do blood tests to check how well your kidneys are working ...
Rituximab is a monoclonal antibody used for the treatment of B-cell non-Hodgkin lymphoma and rheumatoid arthritis. It works by attaching to the CD20 antigen on B-cells, causing cell lysis and antibody-mediated opsonization. AI generated definition based on:Lanzkowsky's Manual of Pediatric Hemato...
The addition of rituximab to the well established CHOP regimens has increased achievable cure rates in diffuse large cell lymphoma, and this combination is now accepted worldwide as standard of care. Although conflicting results are available, rituximab is widely used for the treatment of mantle ...
1.Effectiveness and pharmacoeconomic evaluation of rituximab for treatment of non-Hodgkin s lymphoma;利妥昔单抗对于非霍奇金淋巴瘤的治疗及其药物经济学 2.Rituximab in Combination with CHOP Scheme for Non-Hodgkin s Lymphoma: Evaluation of Clinical Efficacy;利妥昔单抗联合CHOP方案治疗NHL的临床疗效评价 3....
To avoid radiation-induced complications, we used systemic rituximab monotherapy as primary treatment, and present two cases to show its long-term effectiveness for symptomatic primary uveal lymphoma.doi:10.1016/j.ajoc.2019.100484Honeylen Maryl Tiu Teo...
This paper presents a summary of the evidence review group (ERG) report into the clinical and cost-effectiveness of rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma (FNHL) based upon the manufacturer's submission to the National Institute for Health and ...
Effectiveness and pharmacoeconomic evaluation of rituximab for treatment of non-Hodgkin s lymphoma; 利妥昔单抗对于非霍奇金淋巴瘤的治疗及其药物经济学 2. Rituximab in Combination with CHOP Scheme for Non-Hodgkin s Lymphoma: Evaluation of Clinical Efficacy; 利妥昔单抗联合CHOP方案治疗NHL的临床疗效评价...
Rituximab is used ubiquitously in the treatment of B-cell lymphomas, and has set the paradigm the field has been trying to match in drug development. Jonathan W. Friedberg, MD, MMSc Jonathan W. Friedberg, MD, MMSc In any discussion of notable advances in treating lymphoma, rituximab (...